LGM
CGON icon

Logos Global Management’s CG Oncology CGON Stock Holding History

Logos Global Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.9M Buy
575,000
+375,000
+188% +$21.2M 1.94% 15
2025
Q4 		$8.3M Buy
+200,000
New +$8.28M 0.5% 46
2024
Q2 		– Sell
-300,000
Closed -$13.2M – 61
2024
Q1 		$13.2M Buy
+300,000
New +$12.3M 1.07% 27

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Logos Global Management's CGON Position: Q1 2026 in Review

Logos Global Management increased its CG Oncology (CGON) stake by 188% in Q1 2026, buying an estimated $21.2M and bringing the position to 575,000 shares worth $38.9M. The position accounts for 1.94% of the portfolio, ranked #15.

Logos Global Management first reported a position in CGON in Q1 2024 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Logos Global Management held 575,000 shares of CG Oncology worth $38.9M as of Q1 2026.
  • Logos Global Management bought 375,000 CG Oncology shares in Q1 2026, an estimated $21.2M.
  • CG Oncology made up 1.94% of Logos Global Management's portfolio in Q1 2026, its #15 holding.
  • Logos Global Management first reported a position in CG Oncology in Q1 2024 and has held it in 3 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.